Compare · CON vs ELV
CON vs ELV
Side-by-side comparison of Concentra Group Holdings Parent Inc. (CON) and Elevance Health Inc. (ELV): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CON and ELV operate in Medical Specialities (Health Care), so they compete in similar markets.
- ELV is the larger of the two at $92.91B, about 18.6x CON ($4.99B).
- ELV has been more active in the news (3 items in the past 4 weeks vs 2 for CON).
- ELV has more recent analyst coverage (23 ratings vs 14 for CON).
- Company
- Concentra Group Holdings Parent Inc.
- Elevance Health Inc.
- Price
- -
- -
- Market cap
- $4.99B
- $92.91B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NYSE
- NYSE
- IPO
- 2024
- News (4w)
- 2
- 3
- Recent ratings
- 14
- 23
Elevance Health Inc.
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Latest CON
- Jefferies initiated coverage on Concentra with a new price target
- Concentra to Announce Third Quarter 2026 Results on Thursday, November 5, 2026
- Concentra Expands Florida Footprint with New Daytona Beach Medical Center
- Concentra Group Holdings Parent Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
- Concentra Appoints Tanner Newton Chief Financial Officer
- Amendment: SEC Form SCHEDULE 13D/A filed by Concentra Group Holdings Parent Inc.
- Amendment: Director Ortenzio Robert A returned $34,650,000 worth of shares to the company (1,000,000 units at $34.65), decreasing direct ownership by 14% to 4,663,794 units (SEC Form 4)
- Concentra Group Holdings Parent Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
- Director Ortenzio Robert A returned $34,680,000 worth of shares to the company (1,000,000 units at $34.68), decreasing direct ownership by 14% to 4,763,794 units (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13D/A filed by Concentra Group Holdings Parent Inc.
Latest ELV
- SEC Form 4 filed by Elevance Health Inc.
- Elevance Health to Hold Conference Call and Webcast to Discuss Third Quarter 2026 Results on October 21, 2026
- Elevance Health’s Affiliated 2027 Medicare Advantage Plans Advance Stability, Choice and More Coordinated Support
- Elevance Health Inc. filed SEC Form 8-K: Regulation FD Disclosure
- EVP & Chief Legal Officer Wessling Erin M covered exercise/tax liability with 349 shares, decreasing direct ownership by 5% to 7,230 units (SEC Form 4)
- EVP & Chief HR Officer Craig Ryan R covered exercise/tax liability with 144 shares, decreasing direct ownership by 2% to 6,530 units (SEC Form 4)
- Elevance Health Strengthens Connected Cancer Care Model to Support Consumers Through Their Health Journey
- Director Peru Ramiro G bought $366,050 worth of shares (1,000 units at $366.05), increasing direct ownership by 10% to 10,908 units (SEC Form 4)
- President and CEO Boudreaux Gail bought $1,002,230 worth of shares (2,725 units at $367.79), increasing direct ownership by 2% to 171,976 units (SEC Form 4)
- SEC Form 10-Q filed by Elevance Health Inc.